Skip to main content

25mg IG226 (Zonisamide 25 mg)

Pill with imprint 25mg IG226 is White, Capsule-shape and has been identified as Zonisamide 25 mg. It is supplied by Cipla USA, Inc.

Zonisamide is used in the treatment of seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 25mg IG226

Zonisamide

Imprint
25mg IG226
Strength
25 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc.
Manufacturer
InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC)
76282-0226
Inactive Ingredients
microcrystalline cellulose, hydrogenated castor oil, gelatin, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.